Dignitana AB Publishes August Newsletter

Lund, Sweden – 10 August 2018 – Dignitana AB today publishes the August 2018 edition of the company newsletter.

The newsletter is attached here and posted at http://www.dignitana.se/newsletter/. The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders. It is posted to the Dignitana website and is available by email subscription at http://eepurl.com/dwHiLf

Investor Relations

Melissa Bourestom, Dignitana, phone: 00 1 469 518  5031   email:  investorrelations@dignitana.com 

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser.  Learn more at  www.dignitana.se and www.dignicap.com.

Tags:

About Us

Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. DigniCap®is a patented scalp cooling system that offers cancer patients with solid tumors the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. For more information visit www.dignitana.se and www.dignicap.com.

Subscribe

Documents & Links